Transcriptomics

Dataset Information

0

RNA-Seq to probe transcription of patient-derived organotypic colorectal cancer.


ABSTRACT: Patient-derived cancer organoids (PCOs) provide a platform to model resistant to targeted therapies. Following culture maturation, PCOs were treated with stepwise dose escalation of EGFR inhibitors. Cultures were started at 20% physiologic Cmax panitumumab (46ug/ml) and assessed for growth (normalized change in diameter at 96 hours). If cultures surpassed ≥20% growth, stepwise dose escalation was repeated with interval increase of 20% Cmax. Time to resistant (TTR) was defined by duration of time from the initiation of dose escalation to persistent growth at 100% Cmax panitumumab. All samples were collected in triplicate biological replicates at baseline and after achieving resistance to EGFRi with persistent growth at 100% physiologic Cmax. RNA library was constructed using TruSeq Stranded total RNA with rRNA reduction (Illumina). Quality control was performed by Eukaryote Total RNA electrophoresis using NanoDropOne. The library included 2x150bp paired end reads with sequencing performed by NovaSeq 6000 using MiSeq NanoCell at University of Wisconsin Biotechnology Center.

ORGANISM(S): Homo sapiens

PROVIDER: GSE180480 | GEO | 2023/07/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-10-04 | GSE278391 | GEO
2022-07-31 | GSE135617 | GEO
2019-12-01 | GSE128328 | GEO
2022-06-24 | GSE187001 | GEO
2014-07-14 | GSE46036 | GEO
2016-03-08 | GSE78939 | GEO
2021-03-11 | GSE159466 | GEO
2019-10-31 | PXD013937 | Pride
2020-02-14 | GSE145296 | GEO
2022-01-29 | GSE195605 | GEO